MolGen B.V., a global solutions provider of innovative DNA / RNA extraction technology, system, products and kits for human and animal diagnostics, pharma and biotech, has recently opened its UK office.
The new office is located at Sixtth Floor, South Quay Building, 189 Marsh Wall, London, E14 9SH. This expansion will enable the company to meet the increasing demand for cost-efficient, high quality diagnostic services in new markets. The new location will serve as a branch to provide professional laboratories based in London and the UK with access to MolGen’s extraction DNA / RNA portfolio across diagnostics, pharma and the biotech industry. The opening of this new office comes shortly after MolGen opened its US office in San Diego.
Niels Kruize, MolGen CCO, said: “We have been fortunate to experience such rapid growth as a company. Our ability to scale quickly has been a great asset as we continue to strive to meet the growing demand for our innovations. We see this new office as a way to further advance the testing and diagnostics industry and provide solutions as to how the world responds to disease and other life science conditions.”
